• This review focuses on non-coding RNAs in breast cancer. • Growing evidence of their role in cancer progression has emerged. • Diagnostic, prognostic and therapeutic roles have been reported. • Further studies will improve patients care by allowing personalized treatment. • These biomarkers impose considerable bioinformatic support.